TheProfitWatch

IMTX - Immatics N.V. Ordinary Shares

Day 1m 10m 60m PreMarket Market AfterHours Gap
9.5 0.68 (7.16%) --- 0.0 (0.0%) -0.01 (-0.05%) 0.6 (6.32%) 0.1 (0.99%) --- 0.6 (6.32%)

Immatics NV is a biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.

Category: /stock/categories/na
Market Period: Market

Earnings & Ratios

Basic EPS:
Diluted EPS:
Basic P/E:
Diluted P/E:
RSI(14) 1m:
49.55
VWAP:
10.18
RVol:

Events

Period Kind Movement Occurred At

Related News